← ABBOTT LABORATORIES

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $20.9b $27.4b $30.6b $31.9b $34.6b $43.1b $43.7b $40.1b $42.0b $44.3b
Cost of Revenue $9.0b $12.3b $12.7b $13.2b $15.0b $18.5b $19.1b $18.0b $18.7b $19.3b
Gross Profit (Calculated) $11.8b $15.1b $17.9b $18.7b $19.6b $24.5b $24.5b $22.1b $23.2b $25.0b
Research and development $1.4b $2.2b $2.3b $2.4b $2.4b $2.7b $2.9b $2.7b $2.8b $2.9b
Selling, general and administrative $6.7b $9.1b $9.7b $9.8b $9.7b $11.3b $11.2b $10.9b $11.7b $12.3b
Operating expenses:
Operating Income (Loss) $3.2b $1.7b $3.6b $4.5b $5.4b $8.4b $8.4b $6.5b $6.8b $8.1b
Additional Financial Items
Amortization of Intangible Assets $550.0m $2.0b $2.2b $1.9b $2.1b $2.0b $2.0b $2.0b $1.9b $1.7b
Dilutive Common Stock Options (in shares) $6.0m $9.0m $12.0m $13.0m $13.0m $14.0m $11.0m $9.0m $8.0m $7.0m
Earnings before Taxes $1.4b $2.2b $2.9b $4.1b $5.0b $8.2b $8.3b $6.7b $7.0b $8.5b
Foreign Currency Transaction Gain (Loss), before Tax ($495.0m) $34.0m ($28.0m) ($7.0m) $8.0m ($1.0m) ($2.0m) ($41.0m) $27.0m $50.0m
Goodwill, Impairment Loss $0 — — — $0 $0 $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic $306.0m $308.0m ($430.0m) $889.0m $1.6b $3.3b $3.7b $1.2b $947.0m $1.8b
Income (Loss) from Continuing Operations, Per Basic Share $1 $0 $1 $2 $3 $4 $4 $3 $8 $4
Income (Loss) from Continuing Operations, Per Diluted Share $1 $0 $1 $2 $2 $4 $4 $3 $8 $4
Interest income ($99.0m) ($124.0m) ($105.0m) ($94.0m) ($46.0m) ($43.0m) ($183.0m) ($385.0m) ($344.0m) ($308.0m)
Net Earnings $1.4b $477.0m $2.4b $3.7b $4.5b $7.1b $6.9b $5.7b $13.4b $6.5b
Net foreign exchange (gain) loss $495.0m ($34.0m) $28.0m $7.0m ($8.0m) $1.0m $2.0m $41.0m ($27.0m) ($50.0m)
Operating Earnings $3.2b $1.7b $3.6b $4.5b $5.4b $8.4b $8.4b $6.5b $6.8b $8.1b
Taxes on Earnings $350.0m $1.9b $539.0m $390.0m $497.0m $1.1b $1.4b $941.0m ($6.4b) $1.9b
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax $321.0m $124.0m $34.0m — — — — — — —
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1.4b $2.2b $2.9b $4.1b $5.0b $8.2b $8.3b $6.7b $7.0b $8.5b
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $1.1b $353.0m $2.3b $3.7b $4.5b $7.1b $6.9b — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $337.0m $124.0m $34.0m — $24.0m — $0 — — —
Net Income (Loss) Attributable to Parent $1.4b $477.0m $2.4b $3.7b $4.5b $7.1b $6.9b $5.7b $13.4b $6.5b
Net Income (Loss) Available to Common Stockholders, Basic $1.4b $468.0m $2.4b $3.7b $4.5b $7.0b $6.9b $5.7b $13.4b $6.5b
Common Stock, Dividends, Per Share, Declared $0.94 $0.27 $1.34 $2.07 $2.52 $3.97 $3.94 $3.28 $2.24 $2.40
Earnings Per Share, Basic $0.94 $0.27 $1.34 $2.07 $2.52 $3.97 $3.94 $3.28 $7.67 $3.73
Earnings Per Share, Diluted $0.94 $0.27 $1.33 $2.06 $2.50 $3.94 $3.91 $3.26 $7.64 $3.72
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b
Weighted Average Number of Shares Outstanding, Basic 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b
Weighted Average Number of Shares Outstanding, Diluted 1.5b 1.7b 1.8b 1.8b 1.8b 1.8b 1.8b 1.7b 1.7b 1.7b
Cost of products sold, excluding amortization of intangible assets $9.0b $12.3b $12.7b $13.2b $15.0b $18.5b $19.1b $18.0b $18.7b $19.3b
Costs and Expenses $17.7b $25.7b $26.9b $27.4b $29.3b $34.6b $35.3b $33.6b $35.1b $36.3b
Current Income Tax Expense (Benefit) $477.0m $2.8b ($206.0m) $881.0m $605.0m $1.6b $2.0b $1.4b $1.6b $1.5b
Interest Expense $431.0m $904.0m $826.0m $670.0m $546.0m $533.0m $558.0m $637.0m $559.0m $493.0m
Interest Expense (non-operating) — — — — — — — — $559.0m $493.0m
Other (income) expense, net $945.0m ($1.3b) ($139.0m) ($191.0m) ($103.0m) ($277.0m) ($321.0m) ($479.0m) ($376.0m) ($548.0m)
Other Nonoperating Income (Expense) ($945.0m) $1.3b $139.0m $191.0m $103.0m $277.0m $321.0m $479.0m $376.0m $548.0m
Research and Development Expense $1.4b $2.2b $2.3b $2.4b $2.4b $2.7b $2.9b $2.7b $2.8b $2.9b
Selling, General and Administrative Expense $6.7b $9.1b $9.7b $9.8b $9.7b $11.3b $11.2b $10.9b $11.7b $12.3b
Income Tax Expense (Benefit) $350.0m $1.9b $539.0m $390.0m $497.0m $1.1b $1.4b $941.0m ($6.4b) $1.9b
Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component — — — — — — $406.0m $498.0m $542.0m $590.0m
Total Operating Cost and Expenses $17.7b $25.7b $26.9b $27.4b $29.3b $34.6b $35.3b $33.6b $35.1b $36.3b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.